Department of Medicine (Drs Bhat, Farah, Lindenauer, Visintainer, and Pack) and Division of Cardiovascular Medicine (Ms Szalai and Dr Pack), University of Massachusetts Medical School, Baystate Medical Center, Springfield; Department of Public Health Practice, School of Public Health and Health Sciences, University of Massachusetts Amherst (Dr Bhat); Division of Aging, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts (Dr Farah); Center for Health Services and Outcomes Research, Institute of Public Health and Medicine (Dr Lagu) and Division of Hospital Medicine (Dr Lagu), Northwestern Feinberg School of Medicine, Chicago, Illinois; and Institute for Healthcare Delivery & Population Science at University of Massachusetts Medical School-Baystate, Springfield (Drs Lagu, Lindenauer, Visintainer, and Pack).
J Cardiopulm Rehabil Prev. 2021 Jul 1;41(4):257-263. doi: 10.1097/HCR.0000000000000584.
The American Association of Cardiovascular and Pulmonary Rehabilitation (AACVPR) recommends that patients starting cardiac rehabilitation (CR) undergo stratification to identify risk for exercise-related adverse events (AE), but this tool has not been recently evaluated.
Among patients who enrolled in CR in 2016, we used the AACVPR risk stratification tool to evaluate the risk for AE and clinical events (CE). We defined AE as signs or symptoms that precluded or interrupted exercise during CR, and CE as events requiring an urgent evaluation outside of CR exercise sessions.
During the study period, 657 patients with cardiovascular diagnoses were included and classified as high (58%), medium (31%), or low risk (11%). Over the course of CR (76 d, 17 sessions), there were 63 AE and 33 CE. Adverse events were mostly minor (no cardiac arrests or deaths) and managed by CR staff members. When compared with the low- or medium-risk groups, the high-risk group was more likely to have AE (HR 3.0 [95% CI, 1.7-5.9], P = .002) and CE (HR 3.7 [95% CI, 1.5-10.8], P = .002) with fair model discrimination (area under the curve: 0.637, P < .001).
The AACVPR risk stratification tool was predictive of both AE and CE with fair discrimination, although event rates were low and mostly minor. Thus, the AACVPR model may require reevaluation to better identify truly at-risk patients for major AE.
美国心血管和肺康复协会(AACVPR)建议开始心脏康复(CR)的患者进行分层,以确定与运动相关不良事件(AE)的风险,但该工具最近并未得到评估。
在 2016 年参加 CR 的患者中,我们使用 AACVPR 风险分层工具评估 AE 和临床事件(CE)的风险。我们将 AE 定义为在 CR 期间妨碍或中断运动的体征或症状,将 CE 定义为需要在 CR 运动课程之外紧急评估的事件。
在研究期间,纳入了 657 名心血管诊断患者,分为高(58%)、中(31%)或低风险(11%)。在 CR 期间(76 天,17 次),发生了 63 次 AE 和 33 次 CE。不良事件主要为轻微(无心脏骤停或死亡),由 CR 工作人员处理。与低风险或中风险组相比,高风险组更有可能发生 AE(HR 3.0 [95%CI,1.7-5.9],P =.002)和 CE(HR 3.7 [95%CI,1.5-10.8],P =.002),模型区分度中等(曲线下面积:0.637,P <.001)。
AACVPR 风险分层工具对 AE 和 CE 具有中等的预测能力,尽管发生率较低且主要为轻微事件。因此,AACVPR 模型可能需要重新评估,以更好地识别真正存在重大 AE 风险的患者。